Search filters

List of works by Maurizio Zangari

A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma

scientific article published on 24 February 2015

A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.

scientific article published on October 2007

A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients ⬇️

scientific article published on October 15, 2010

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

scientific article published on 14 November 2006

Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism.

scientific article

Adverse Metaphase Cytogenetics Can Be Overcome by Adding Bortezomib and Thalidomide to Fractionated Melphalan Transplants

scientific article published on 3 November 2016

Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients

scientific article published in June 2011

Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2 ⬇️

scientific article published on December 1, 2010

Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma

scientific article published on 3 October 2016

Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy

scientific article published on 13 June 2005

Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profiling

scientific article published in December 2007

Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma

scientific article published on December 2010

Bleeding disorders associated with cancer dysproteinemias

scientific article

Bone and paraproteinemias

scientific article published on September 2010

Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma

scientific article

Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.

scientific article published on 6 April 2017

Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience

scientific article published in 2022

Could hypoxia increase the prevalence of thrombotic complications in polycythemia vera? ⬇️

scientific article published on April 1, 2013

Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.

scientific article

Cytomegalovirus Reactivation Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma in the Era of Novel Chemotherapeutics and Tandem Transplantation ⬇️

scientific article published on June 19, 2012

Cytotoxic chemotherapy following tandem autotransplants in multiple myeloma patients

scientific article published in October 2002

DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma

scientific article

Daratumumab in high-risk relapsed/refractory multiple myeloma patients: adverse effect of chromosome 1q21 gain/amplification and GEP70 status on outcome

scientific article published on 09 December 2019

Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation

scientific article

Drug resistance in hematologic malignancies: induction mechanisms, genetics, and therapeutics.

scientific article published on 27 April 2015

Effect of low-dose bortezomib on bone formation in smouldering multiple myeloma

scientific article published on 24 March 2018

Effect of time to infusion of autologous stem cells (24 vs. 48 h) after high‐dose melphalan in patients with multiple myeloma ⬇️

scientific article published on May 31, 2012

Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients

scientific article published in October 2007

Eight-year median survival in multiple myeloma after total therapy 2: roles of thalidomide and consolidation chemotherapy in the context of total therapy 1.

scientific article published on 26 March 2008

Endothelial dysfunction in antiangiogenesis-associated thrombosis

scientific article published in July 2002

Estimation of daily proteinuria in patients with multiple myeloma by using the protein-to-creatinine ratio in random urine samples

scientific article published on 27 April 2010

Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma

scientific article published on 5 May 2015

Evolving indications for hematopoietic stem cell transplantation in multiple myeloma and other plasma cell disorders

scientific article published on January 2009

Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple Myeloma.

scientific article published on 27 February 2017

Farnesyltransferase inhibitors and rapamycin in the treatment of multiple myeloma

scientific article published on December 2006

Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120).

scientific article published on 28 May 2015

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis

scientific article published on 5 October 2006

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

scientific article

Hemostatic dysfunction in paraproteinemias and amyloidosis

scientific article published on June 2007

Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma

scientific article published in June 2008

High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis

scientific article

High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients

scientific article published on April 2008

High-dose therapy and immunomodulatory drugs in multiple myeloma

scientific article

Hyperammonemia and encephalopathy in patients with multiple myeloma

scientific article published in May 2007

Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism

scientific article

Hypothyroidism in patients with multiple myeloma following treatment with thalidomide

scientific article published in April 2002

Impact of bortezomib on bone health in myeloma: A review of current evidence ⬇️

scientific article published on 09 January 2012

Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model

scientific article

Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease

scientific article published on 04 February 2014

Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma

scientific article published on 21 April 2017

Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens

scientific article

Low‐risk identification in multiple myeloma using a new 14‐gene model ⬇️

scientific article published on July 1, 2012

Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes

article

Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?

scientific article published on 17 February 2016

Monoclonal gammopathy of undetermined significance: a consensus statement

scientific article

Multiple myeloma presenting as CEA-producing rectal cancer ⬇️

scientific article published on March 31, 2010

Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations

scientific article

NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers ⬇️

scientific article published on January 14, 2013

Oral administration of analgesia and anxiolysis for pain associated with bone marrow biopsy.

scientific article

Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance

scientific article

Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma

scientific article

Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases

scientific article published in April 2003

Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II.

scientific article

Progress in myeloma stem cells ⬇️

scientific article published on September 8, 2011

RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma

scientific article published on 20 May 2009

Response to bortezomib and activation of osteoblasts in multiple myeloma

scientific article published on September 2006

Response to bortezomib in refractory type I cryoglobulinemia

scientific article published in November 2008

Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma

scientific article published in October 2005

Surgical thyroparathyroidectomy prevents progression of 5TGM1 murine multiple myeloma in vivo.

scientific article published on 23 February 2018

Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone

scientific article published on 9 November 2009

Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2.

scientific article published on March 2008

Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics

scientific article

Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival

scientific article published in June 2003

Thalidomide and hematopoietic-cell transplantation for multiple myeloma

scientific article published in March 2006

Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities

scientific article published on 20 May 2008

Thalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia

scientific article published in June 2002

The Arkansas approach to therapy of patients with multiple myeloma

scientific article published on December 2007

The blood coagulation mechanism in multiple myeloma

scientific article

The effects of proteasome inhibitors on bone remodeling in multiple myeloma

scientific article

The hemostatic system and malignancy

scientific article published on August 2008

The molecular classification of multiple myeloma

scientific article

The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma

scientific article published on 5 July 2018

The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype

scientific article published on 18 May 2017

The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo

scientific article published on January 2009

Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy

scientific article published in August 2002

Thrombosis in multiple myeloma

scientific article (publication date: March 2007)

Thrombotic events in patients with cancer receiving antiangiogenesis agents

scientific article published on 24 August 2009

Thymic PTH Increases after Thyroparathyroidectomy in C57BL6/KaLwRij Mice

scientific article published on 25 January 2018

Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies

scientific article published in December 2005

Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma

scientific article published in June 2018

Paulina is supported by:

About Paulina

Help